P312: Evaluating the role of bevacizumab in reducing epistaxis in patients with hereditary hemorrhagic telangiectasia: A systematic review and meta-analysis
Saved in:
| Main Authors: | Paulo Victor Zattar Ribeiro, Gabriel Henrique Simoni, Verônica Cardoso, Pedro Carrión Carvalho, Yasmin Esgaib, Richards Sousa, Lina Omais, Juliana Dutra, Giovanna Susin, Alef Perini, Mariana Simoni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Genetics in Medicine Open |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949774425003164 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab
by: Muaaz Masood, et al.
Published: (2021-01-01) -
Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report
by: Meir Mei-Zahav, et al.
Published: (2017-10-01) -
Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
by: John M. Lee, et al.
Published: (2019-10-01) -
Pericardial Involvement in Hereditary Hemorrhagic Telangiectasia
by: Abir Derbel, et al.
Published: (2025-01-01) -
Brain abscess and hereditary hemorrhagic telangiectasia
by: Leonardo Furtado FREITAS, et al.
Published: (2022-03-01)